Wealthfront Advisers’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.77M | Sell |
23,447
-2,797
| -11% | -$323K | 0.01% | 560 |
|
|
2026
Q1 | $3.14M | Sell |
26,244
-2,847
| -10% | -$373K | 0.01% | 520 |
|
|
2025
Q4 | $3.96M | Sell |
29,091
-512
| -2% | -$73.6K | 0.01% | 450 |
|
|
2025
Q3 | $4.37M | Buy |
29,603
+2,556
| +9% | +$354K | 0.01% | 415 |
|
|
2025
Q2 | $3.5M | Buy |
27,047
+1,507
| +6% | +$183K | 0.01% | 446 |
|
|
2025
Q1 | $3.05M | Buy |
25,540
+924
| +4% | +$115K | 0.01% | 445 |
|
|
2024
Q4 | $2.86M | Buy |
24,616
+710
| +3% | +$89.8K | 0.01% | 443 |
|
|
2024
Q3 | $3.23M | Sell |
23,906
-2,240
| -9% | -$300K | 0.01% | 396 |
|
|
2024
Q2 | $3.55M | Sell |
26,146
-355
| -1% | -$48.3K | 0.01% | 353 |
|
|
2024
Q1 | $3.42M | Buy |
26,501
+1,463
| +6% | +$177K | 0.01% | 362 |
|
|
2023
Q4 | $2.86M | Sell |
25,038
-783
| -3% | -$78.1K | 0.01% | 374 |
|
|
2023
Q3 | $2.35M | Sell |
25,821
-6,337
| -20% | -$654K | 0.01% | 391 |
|
|
2023
Q2 | $3.62M | Buy |
32,158
+2,353
| +8% | +$249K | 0.02% | 284 |
|
|
2023
Q1 | $3.12M | Sell |
29,805
-1,002
| -3% | -$105K | 0.01% | 301 |
|
|
2022
Q4 | $3.41M | Sell |
30,807
-5,490
| -15% | -$575K | 0.02% | 271 |
|
|
2022
Q3 | $3.17M | Buy |
36,297
+4,998
| +16% | +$454K | 0.02% | 267 |
|
|
2022
Q2 | $2.45M | Buy |
31,299
+9,474
| +43% | +$782K | 0.01% | 328 |
|
|
2022
Q1 | $1.86M | Buy |
21,825
+17,516
| +406% | +$1.68M | 0.01% | 413 |
|
|
2021
Q4 | $516K | Sell |
4,309
-8,281
| -66% | -$1.03M | ﹤0.01% | 586 |
|
|
2021
Q3 | $1.56M | Buy |
12,590
+7,820
| +164% | +$1.01M | 0.01% | 397 |
|
|
2021
Q2 | $572K | Buy |
4,770
+636
| +15% | +$72.6K | ﹤0.01% | 507 |
|
|
2021
Q1 | $435K | Buy |
4,134
+16
| +0.4% | +$1.62K | ﹤0.01% | 474 |
|
|
2020
Q4 | $420K | Buy |
4,118
+374
| +10% | +$35.2K | ﹤0.01% | 457 |
|
|
2020
Q3 | $315K | Buy |
3,744
+622
| +20% | +$48.4K | ﹤0.01% | 458 |
|
|
2020
Q2 | $203K | Sell |
3,122
-565
| -15% | -$37.3K | ﹤0.01% | 497 |
|
|
2020
Q1 | $240K | Sell |
3,687
-580
| -14% | -$45.7K | ﹤0.01% | 413 |
|
|
2019
Q4 | $336K | Sell |
4,267
-205
| -5% | -$16K | ﹤0.01% | 441 |
|
|
2019
Q3 | $356K | Sell |
4,472
-181
| -4% | -$14.2K | ﹤0.01% | 413 |
|
|
2019
Q2 | $389K | Buy |
4,653
+350
| +8% | +$27.9K | ﹤0.01% | 409 |
|
|
2019
Q1 | $340K | Buy |
4,303
+339
| +9% | +$24.7K | ﹤0.01% | 410 |
|
|
2018
Q4 | $264K | Buy |
+3,964
| New | +$274K | ﹤0.01% | 410 |
|
Other funds holding XYL
Wealthfront Advisers's XYL Position: Q2 2026 in Review
Wealthfront Advisers reduced its Xylem (XYL) stake by 11% in Q2 2026, selling an estimated $323K and leaving 23,447 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #560.
Wealthfront Advisers first reported a position in XYL in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.37M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Wealthfront Advisers held 23,447 shares of Xylem worth $2.77M as of Q2 2026.
- Wealthfront Advisers sold 2,797 Xylem shares in Q2 2026, an estimated $323K.
- Xylem made up 0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #560 holding.
- Wealthfront Advisers first reported a position in Xylem in Q4 2018 and has held it in 31 quarters since.
- Wealthfront Advisers's Xylem position peaked at $4.37M in Q3 2025.
- 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.